TheJobsMapRenBio jobs and careers
About RenBio
RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA blueprint and antibody factory.
Founded in 2016 by David Ho and Yaoxing Huang.
- Founded
- 2016
- Employees
- 11 to 50
- Total funding
- $43.9M
Leadership
The top of RenBio's org chart, with how many people report into each leader.
David D. Ho
Founder
14 reports
Rachel A. Liberatore
President & Chief Scientific Officer
8 reports
Sheila Ramerman
Partner
Meredith Brown-Tuttle
Partner
Martin Markowitz
Partner
Jim Ackland
Partner
Robert Miller
Director of Development
Yaoxing Huang
Co-Founder
Jobs at RenBio
No open positions right now. Explore more companies on TheJobsMap.